4-(Bromomethyl)-1-methylpiperidine, 98+%, 250mg

Ethene-1,1-diylbis(diphenylphosphine), 95.0%, 5g

5-butyl-1,3,4-thiadiazol-2-amine, 95.0%, 5g

4-Chloro-n-ethyl-2-fluorobenzenesulfonamide, 95%, 250mg

4-Bromo-N-(4-fluoro-3-(trifluoromethyl)phenyl)benzenesulfonamide, 97%, 1g

Connecting piece GL T-shape, GL 14, 1 Piece

N1,N1-Bis(2-(dimethylamino)ethyl)-N2,N2-dimethylethane-1,2-diamine, 95.0%, 25g

4-(Methoxymethyl)piperidine hydrochloride, 95.0%, 10g

GC capillary column ROTI®Cap-5 MS Ultra, 12 m, 0.20 mm, 0.35 µm, 1 Piece(s)

N-(4-methoxybenzyl)glycine, 95.0%, 5g

3-(Morpholin-4-ylmethyl)benzoic acid, 97.0%, 10g

5-[1-(4-chloro-3-methylphenoxy)ethyl]-4-methyl-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

cis-2-Octene, 95.0%, 1ml